JOURNAL OF MEDICAL VIROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2021-05-11 ms3000001817756113

12820号了，有投稿的吗

66 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-06-29 洛洛仔111

惊呆了，一下子变成了20+的杂志Q1。目瞪口呆

53 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-12-03 ms8000001944553936 来自广东省

偏重的研究方向：冠状病毒
经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提

71 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-07-22 ms7000002060127384

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：混合感染;冠状病毒
经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的

65 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-07-06 14856b50m82暂无昵称

偏重的研究方向：新冠;临床
经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就

41 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2023-03-02 ms4000000252827097 来自湖南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：新冠
经验分享：under review 快2个月没反应啥情况啊

92 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2023-06-06 wanzhengwei 来自约旦

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：HIV;病毒学;HPV
经验分享：投稿一个月后大修，返修后一个月接收，较顺利。

51 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-08-18 rrrutin

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：病毒学
经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。

夸一下新投稿系统，非常好用。

130 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2023-07-08 2007007 来自堪萨斯

偏重的研究方向：HIV;感染病学
经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=964688, encodeId=f965964688d4, content=12820号了，有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0c5463702, createdName=ms3000001817756113, createdTime=Tue May 11 19:35:56 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229375, encodeId=01d312293e52b, content=惊呆了，一下子变成了20+的杂志Q1。目瞪口呆, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Jun 29 09:01:34 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104167, encodeId=5beb210416ea2, content=偏重的研究方向：冠状病毒 经验分享：年终总结，发表了两篇这个杂志，被批评了，说灌水，发表这个杂志最好不要提, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e838263314, createdName=ms8000001944553936, createdTime=Sat Dec 03 22:58:19 CST 2022, time=2022-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234063, encodeId=4bb71234063d9, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：混合感染;冠状病毒 经验分享：想问问大家Under Review（大写），是外审了还是还在编辑手里，已经13天了，是用新的投稿系统投的，有关冠状病毒混合感染方面的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:43:09 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230987, encodeId=7ad1123098e57, content=偏重的研究方向：新冠;临床 经验分享：现在投稿是不是就会直接凉凉，会不会要求很高了那就, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Jul 06 19:53:29 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117303, encodeId=624e211e30330, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：新冠 经验分享：under review 快2个月没反应啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=585a5690427, createdName=ms4000000252827097, createdTime=Thu Mar 02 23:31:43 CST 2023, time=2023-03-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2141098, encodeId=a1152141098f3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：HIV;病毒学;HPV 经验分享：投稿一个月后大修，返修后一个月接收，较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ba1b5490572, createdName=wanzhengwei, createdTime=Tue Jun 06 17:12:34 CST 2023, time=2023-06-06, status=1, ipAttribution=约旦), GetPortalCommentsPageByObjectIdResponse(id=1239444, encodeId=a73112394446d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：病毒学 经验分享：两个审稿人，投稿-大修-接收加起来不到两个月。 夸一下新投稿系统，非常好用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220818/9ecf7deb49b7402c92c7fd924e881fb9/75d87fc3b5fb4ed1a6a048908118dcce.jpg, createdBy=b6291929673, createdName=rrrutin, createdTime=Thu Aug 18 09:48:04 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146897, encodeId=8aca214689e55, content=偏重的研究方向：HIV;感染病学 经验分享：今年有投稿的么？一个月了还是under review，着急发啊，虽然影响因子掉下去很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Sat Jul 08 00:05:04 CST 2023, time=2023-07-08, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=1234065, encodeId=873b1234065ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：冠状病毒;病毒流行病学;临床 经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2fc6524549, createdName=ms7000002060127384, createdTime=Fri Jul 22 19:54:37 CST 2022, time=2022-07-22, status=1, ipAttribution=)]

2022-07-22 ms7000002060127384

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：冠状病毒;病毒流行病学;临床
经验分享：想问问大家Under Review（大写）是外审了还是还在编辑手里，已经13天了

54 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务